Medicine and Health

Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial

D. H. Ryan, I. Lingvay, et al.

Discover how semaglutide can transform weight management for adults with cardiovascular disease. This analysis of the SELECT trial showcases impressive long-term weight loss and anthropometric improvements, conducted by a team of experts including Donna H. Ryan and Ildiko Lingvay.

00:00

Playback language: English

Related Publications

Explore these studies to deepen your understanding of the subject.

Medicine and Health

Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial

D. H. Ryan, I. Lingvay, et al.

Medicine and Health

Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial

H. M. Colhoun, I. Lingvay, et al.

Medicine and Health

Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial

J. F. E. Mann, P. Rossing, et al.

Medicine and Health

Effects of Mediterranean diet during pregnancy on the onset of overweight or obesity in the offspring: a randomized trial

S. Coppola, L. Paparo, et al.

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 12+ languages.

No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny